These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 28803183)

  • 1. Chronic Urticaria Patient Perspective (CUPP): The First Validated Tool for Assessing Quality of Life in Clinical Practice.
    Baiardini I; Braido F; Molinengo G; Caminati M; Costantino M; Cristaudo A; Crivellaro M; Ferrucci SM; Gallo R; Giorgis V; Legori A; Loera B; Martignago I; Marzano AV; Morrone A; Parente R; Parodi A; Parolo A; Peveri S; Pigatto P; Radice A; Ridolo E; Rolla G; Roncallo C; Rossi O; Savi E; Senna G; Triggiani M; Canonica GW
    J Allergy Clin Immunol Pract; 2018; 6(1):208-218. PubMed ID: 28803183
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Psychometric properties of the Spanish version of the once-daily Urticaria Activity Score (UAS) in patients with chronic spontaneous urticaria managed in clinical practice (the EVALUAS study).
    Jauregui I; Gimenez-Arnau A; Bartra J; Labrador-Horrillo M; de Frutos JO; Silvestre JF; Sastre J; Velasco M; Ferrer M; Ballesteros C; Valero A
    Health Qual Life Outcomes; 2019 Jan; 17(1):23. PubMed ID: 30704532
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical evaluation of the computerized chronic urticaria-specific quality of life questionnaire in Korean patients with chronic urticaria.
    Ye YM; Park JW; Kim SH; Choi JH; Hur GY; Lee HY; Lee EH; Park HS
    Clin Exp Dermatol; 2012 Oct; 37(7):722-8. PubMed ID: 22731761
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Minimal clinical important difference (MCID) of the Thai Chronic Urticaria Quality of Life Questionnaire (CU-Q2oL).
    Kulthanan K; Chularojanamontri L; Tuchinda P; Rujitharanawong C; Baiardini I; Braido F
    Asian Pac J Allergy Immunol; 2016 Jun; 34(2):137-45. PubMed ID: 27007835
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adaptation and validation of the Bengali version of the Chronic Urticaria Quality of Life Questionnaire (CU-Q2oL).
    Dhabal A; Mondal H; Mondal S; Baiardini I; Chakraborty SS; Chakraborty T; Podder I
    Indian J Dermatol Venereol Leprol; 2023; 89(3):385-392. PubMed ID: 36331856
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adaptation and Validation of the Israeli Version of the Chronic Urticaria Quality of Life Questionnaire (CU-Q2oL).
    Kessel A; Graif Y; Vadasz Z; Schichter-Konfino V; Almog M; Cohen S; Teplitski V; Stein N; Baiardini I; Maurer M; Toubi E
    Isr Med Assoc J; 2016 Aug; 18(8):461-465. PubMed ID: 28471576
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Turkish version of the chronic urticaria quality of life questionnaire: cultural adaptation, assessment of reliability and validity.
    Kocatürk E; Weller K; Martus P; Aktas S; Kavala M; Sarigul S; Baiardini I; Canonica GW; Brzoza Z; Kalogeromitros D; Maurer M
    Acta Derm Venereol; 2012 Jul; 92(4):419-25. PubMed ID: 21918791
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The persian version of the chronic urticaria quality of life questionnaire: factor analysis, validation, and initial clinical findings.
    Tavakol M; Mohammadinejad P; Baiardini I; Braido F; Gharagozlou M; Aghamohammadi A; Nabavi M; Dabbaghzade A; Tavakol Z; Afarideh M; Rezaei N
    Iran J Allergy Asthma Immunol; 2014 Aug; 13(4):278-85. PubMed ID: 24659164
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adaptation and validation of the Spanish version of the Chronic Urticaria Quality of Life Questionnaire (CU-Q2oL).
    Valero A; Herdman M; Bartra J; Ferrer M; Jáuregui I; Dávila I; del Cuvillo A; Montoro J; Mullol J; Sastre J; Canonica GW; Baiardini I
    J Investig Allergol Clin Immunol; 2008; 18(6):426-32. PubMed ID: 19123433
    [TBL] [Abstract][Full Text] [Related]  

  • 10. RhinAsthma patient perspective: a short daily asthma and rhinitis QoL assessment.
    Braido F; Baiardini I; Stagi E; Scichilone N; Rossi O; Lombardi C; Ridolo E; Gani F; Balestracci S; Girbino G; Senna GE; Bordo A; Church MK; Canonica GW
    Allergy; 2012 Nov; 67(11):1443-50. PubMed ID: 22978345
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Disease activity only moderately correlates with quality of life impairment in patients with chronic spontaneous urticaria.
    Koti I; Weller K; Makris M; Tiligada E; Psaltopoulou T; Papageorgiou C; Baiardini I; Panagiotakos D; Braido F; Maurer M
    Dermatology; 2013; 226(4):371-9. PubMed ID: 23942323
    [TBL] [Abstract][Full Text] [Related]  

  • 12. How to assess disease activity in patients with chronic urticaria?
    Młynek A; Zalewska-Janowska A; Martus P; Staubach P; Zuberbier T; Maurer M
    Allergy; 2008 Jun; 63(6):777-80. PubMed ID: 18445192
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Portuguese version of Rhinitis and Asthma Patient's Perspective (RAPP): Validation and assessment.
    Todo-Bom A; Braido F; Molinengo G; Loureiro C; Canonica GW; Baiardini I
    Pulmonology; 2020; 26(2):73-77. PubMed ID: 30737172
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Urticaria Activity Score-Validity, Reliability, and Responsiveness.
    Hawro T; Ohanyan T; Schoepke N; Metz M; Peveling-Oberhag A; Staubach P; Maurer M; Weller K
    J Allergy Clin Immunol Pract; 2018; 6(4):1185-1190.e1. PubMed ID: 29128337
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluating the minimally important difference of the urticaria activity score and other measures of disease activity in patients with chronic idiopathic urticaria.
    Mathias SD; Crosby RD; Zazzali JL; Maurer M; Saini SS
    Ann Allergy Asthma Immunol; 2012 Jan; 108(1):20-24. PubMed ID: 22192960
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cross-cultural adaptation of the Brazilian-Portuguese version of the chronic urticaria quality-of-life questionnaire - CU-Q2oL.
    Dias GA; Pires GV; Valle SO; França AT; Papi JA; Dortas SD; Levy SA; Baiardini I; Canonica GW
    Allergy; 2011 Nov; 66(11):1487-93. PubMed ID: 21899558
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development and validation of the Cholinergic Urticaria Quality-of-Life Questionnaire (CholU-QoL).
    Ruft J; Asady A; Staubach P; Casale T; Sussmann G; Zuberbier T; Maurer M; Weller K; Altrichter S
    Clin Exp Allergy; 2018 Apr; 48(4):433-444. PubMed ID: 29369455
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Ostomy-Q: Development and Psychometric Validation of an Instrument to Evaluate Outcomes Associated with Ostomy Appliances.
    Nafees B; Rasmussen M; LLoyd A
    Ostomy Wound Manage; 2017 Jan; 63(1):12-22. PubMed ID: 28112646
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Validity and responsiveness of the Urticaria Activity and Impact Measure: A new patient-reported tool.
    Maurer M; Mathias SD; Crosby RD; Rajput Y; Zazzali JL
    Ann Allergy Asthma Immunol; 2018 Jun; 120(6):641-647. PubMed ID: 29567359
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The cross-cultural validation of the English version of RhinAsthma patient's perspective (RAPP).
    Lim MC; Baiardini I; Molinengo G; Navarro-Locsin CG; Canonica GW; Braido F
    J Asthma; 2020 Jun; 57(6):680-686. PubMed ID: 30907184
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.